Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-12

Clinical Trial Update: Use of Tapentadol Oral Solution for Pain After Surgery in Children From Newborn to Less Than 2 Years Old [Phase 2]

View source ↗

Summary

Phase 2 trial investigating tapentadol oral solution for postoperative pain in children under 2; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tapentadol (Tapentadol hydrochloride)

Snippet

Sponsor: Grünenthal GmbH | Conditions: Moderate to Severe Acute Postoperative Pain | Phase 2 | Status: TERMINATED | Results posted: 2017-12-12